PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size - New storage space part of $18-million expansion doubling size of Metrics’ facility in 2008
Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size

 

NewswireToday - /newswire/ - Raleigh, NC, United States, 2008/04/02 - New storage space part of $18-million expansion doubling size of Metrics’ facility in 2008.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In a move that boosts its capacity for service by 50 percent, Metrics Inc. is expanding its stability storage.

In its latest expansion, Metrics will offer new environmental specialties (ESI) chambers with redundant mechanical systems that will maintain proper environmental conditions, even in the unlikely event that an electrical failure occurs. All environmental chambers are state of the art and will be fully operational and validated by second quarter 2008. The chambers meet International Conference on Harmonization (ICH) and United States Pharmacopia (USP) guidelines.

In addition, for chambers without such redundancy, Metrics will maintain empty back-up chambers pre-set to condition so that client studies can be transferred immediately if necessary.

Finally, the new storage facility is highly secure, with access to the area being strictly limited to authorized personnel only.

“Since we’ve been functioning at capacity at Metrics for some time now, we are pleased we can now provide our clients with the greater stability storage capacity they need,” said Phil Hodges, president.

Headquartered in Greenville, N.C., Metrics is one of the fastest-growing contract pharmaceutical development laboratories in the United States. The company provides quality pharmaceutical formulation, clinical trial material (Phase I through Phase III) and commercial manufacturing, and analytical development/validation services to the pharmaceutical industry.

Metrics is completing an $18-million, 47,000-square-foot facility addition that will nearly double its analytical and manufacturing space. The expansion is taking place at Metrics’ existing 50,000-square-foot cGMP facility registered with and inspected by the FDA.

Not only will Metrics be able to increase production to 1 billion tablets a year (up from the current level of 50 million), but space for microbiology services will increase five-fold. Metrics offers a full menu of microbiological services to support non-sterile solid dosage forms.

Moreover, the Metrics microbiology department routinely performs bacterial endotoxin and particulate matter testing on parenterals. This year, Metrics will bring antibiotic assay and sterility testing online, enhancing its ability to offer full microbiological support of sterile products.

Since its start in 1994, Metrics has grown from four employees to more than 230 employees and experienced double-digit annual revenue growth.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Metrics Expands Stability Storage New Storage Part of $18M Expansion Doubling Metrics' Size

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Karen Stinneford 
919-833-9102 kstinneford[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sinclair & Co. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)